Prognosis
Pfizer Seeks U.S. Clearance for Covid Boosters for Older Teens
- Variant fears have sparked push to open up access to boosters
- Drugmaker seeks to provide ‘strong protection’ for large group
This article is for subscribers only.
Pfizer Inc.’s chief executive said the company has asked the U.S. to allow Covid-19 booster shots for people age 16-17, a move that would expand access to additional doses amid worry about the new omicron virus variant.
Albert Bourla said in a tweet Tuesday that the company asked the Food and Drug Administration for emergency authorization of third doses for the age group. Shares of the drugmaker, which rose 2.5% in regular trading, gained 0.7% after hours in New York.